BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT06153238-completion@plaintrial.com
DTSTAMP:20261027T202116Z
DTSTART;VALUE=DATE:202606
SUMMARY:A PK Study to Compare GME751 (Proposed Pembrolizumab Biosimilar) an
 d US-licensed and EU-authorized Keytruda® in Participants With Stage II a
 nd III Melanoma — estimated completion date
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT06153238
URL:https://plaintrial.com/trial/NCT06153238
END:VEVENT
END:VCALENDAR